Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John L. Lamattina currently holds 2,938 shares of LIGAND PHARMACEUTICALS INC (LGND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John L. Lamattina has been a net seller of LGND stock. They have purchased $250.1K and sold $6.5M worth of shares.
John L. Lamattina's most recent insider trade was on Jun 5, 2026, when they sold 2,938 shares at $0.00 per share.
John L. Lamattina serves as Executive at LIGAND PHARMACEUTICALS INC (LGND). They have executed 86 insider transactions totaling $6.8M over their tenure at the company.
John L. Lamattina holds the position of Executive at LIGAND PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
John L. Lamattina has shown a selling trading pattern, with $250.1K in total purchases and $6.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John L. Lamattina was on Sep 4, 2018, when they sold $850.3K worth of LGND shares. This transaction involved 3,335 shares at $254.96 per share.
John L. Lamattina currently owns 2,938 shares of LIGAND PHARMACEUTICALS INC (LGND), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John L. Lamattina's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John L. Lamattina has 86 Form 4 filings on record as an insider at LIGAND PHARMACEUTICALS INC.
Set alerts for John L. Lamattina and 40,000+ other insiders.